Frontage Holdings (HKSE:01521) Pre-Tax Income : HK$114 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Frontage Holdings's pretax income for the six months ended in Dec. 2023 was HK$56 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$114 Mil. Frontage Holdings's pretax margin was 5.45%.

During the past 8 years, Frontage Holdings's highest Pretax Margin was 22.97%. The lowest was 5.61%. And the median was 16.24%.

Frontage Holdings Pre-Tax Income Historical Data

The historical data trend for Frontage Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings Pre-Tax Income Chart

Frontage Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

162.83

151.33

195.49

281.02

113.84

Frontage Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial									106.04	140.72	141.43	58.02	56.00

Competitive Comparison of Frontage Holdings's Pre-Tax Income

For the Biotechnology subindustry, Frontage Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontage Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's Pre-Tax Income falls into.

Frontage Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Frontage Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	159.687	+	0	+	-55.231	+	13.706	+	-4.319
	=	114

Frontage Holdings's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	87.134	+	0	+	-30.942	+	7.466	+	-7.662
	=	56

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$114 Mil.

Frontage Holdings (HKSE:01521) Pre-Tax Income Explanation

Frontage Holdings's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	55.996	/	1026.981
	=	5.45%

During the past 8 years, Frontage Holdings's highest Pretax Margin was 22.97%. The lowest was 5.61%. And the median was 16.24%.

Frontage Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontage Holdings (HKSE:01521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

FGHQF:USA

Address

700 Pennsylvania Drive, Exton, PA, USA, 19341

Website

https://www.frontagelab.com

Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.

Frontage Holdings (HKSE:01521) Headlines

No Headlines